As Lina Khan, chair of the Federal Trade Commission, ends her tenure this week the FTC posted a second report in six months ...

The new document focuses on the influence of PBMs over the market for specialty generic drugs for illnesses like cancer, ...

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.

Longstanding claims that one of the reasons for high drug prices in the US is the actions of pharmacy benefit management (PBM) companies – the middlemen in the supply chain – are being ...

The Iowa Pharmacy Association is calling for reform from Iowa lawmakers after 29 pharmacies closed last year, including some ...

selling a version of Humira for $584 for cash-paying customers without involving a PBM. Typically, PBMs are the entities in the prescription drug supply chain that negotiate net prices and ...